日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

铁死亡是代谢功能障碍相关脂肪肝疾病中一个可靶向治疗的有害因素。

Peleman, Cédric; Hellemans, Stig; Veeckmans, Geraldine; Arras, Wout; Zheng, Hao; Koeken, Ine; Van San, Emily; Hassannia, Behrouz; Walravens, Magali; Kayirangwa, Edissa; Beyene, Nateneal Tamerat; Van Herck, Mikhaïl Alfons; De Vos, Winnok Harald; Pintelon, Isabel; van Nassauw, Luc; Oosterlinck, Baptiste; Smet, Annemieke; Vits, Lieve; Dirinck, Eveline; Verrijken, An; De Man, Joris; Van Eyck, Annelies; Kwanten, Wilhelmus Josephus; Vonghia, Luisa; Driessen, Ann; Augustyns, Koen; Toyokuni, Shinya; De Winter, Benedicte; Van Steenkiste, Christophe; Francque, Sven; Vanden Berghe, Tom

Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression

铁死亡导致多发性硬化症,其药物靶向作用可抑制实验性疾病进展

Emily Van San, Angela C Debruyne, Geraldine Veeckmans, Yulia Y Tyurina, Vladimir A Tyurin, Hao Zheng, Sze Men Choi, Koen Augustyns, Geert van Loo, Bernhard Michalke, Vivek Venkataramani, Shinya Toyokuni, Hülya Bayir, Peter Vandenabeele, Behrouz Hassannia, Tom Vanden Berghe